Seguir
Ernesto Sosa
Ernesto Sosa
Hospital de Especialidades Centro Médico Nacional Siglo XXI
No hay ninguna dirección de correo electrónico verificada.
Título
Citado por
Citado por
Año
Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic
M Mercado, B Gonzalez, G Vargas, C Ramirez, ALE de los Monteros, ...
The Journal of Clinical Endocrinology & Metabolism 99 (12), 4438-4446, 2014
2112014
Are there really any predictive factors for a successful weight loss after bariatric surgery?
D Cadena-Obando, C Ramírez-Rentería, A Ferreira-Hermosillo, ...
BMC endocrine disorders 20, 1-8, 2020
1222020
Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism
AL Espinosa-de-los-Monteros, B González, G Vargas, E Sosa, M Mercado
Pituitary 14, 231-235, 2011
752011
Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly
M Mercado, B González, C Sandoval, Y Esquenazi, F Mier, G Vargas, ...
The Journal of Clinical Endocrinology & Metabolism 93 (9), 3411-3415, 2008
702008
Giant prolactinomas: are they really different from ordinary macroprolactinomas?
E Espinosa, E Sosa, V Mendoza, C Ramírez, V Melgar, M Mercado
Endocrine 52, 652-659, 2016
682016
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas
I Shimon, E Sosa, V Mendoza, Y Greenman, A Tirosh, E Espinosa, ...
Pituitary 19, 429-436, 2016
672016
Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor
I Hernandez, AL Espinosa-de-los-Monteros, V Mendoza, S Cheng, ...
Archives of Medical Research 37 (8), 976-980, 2006
622006
Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma
R Sánchez, AL Espinosa-de-los-Monteros, V Mendoza, E Brea, ...
Archives of medical research 33 (5), 478-481, 2002
622002
Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
C Ramírez, G Vargas, B González, A Grossman, J Rábago, E Sosa, ...
European Journal of Endocrinology 166 (1), 21-26, 2012
602012
Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status
AL Espinosa‐de‐los‐Monteros, E Sosa, S Cheng, R Ochoa, C Sandoval, ...
Clinical Endocrinology 64 (3), 245-249, 2006
582006
Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease
M Mercado, AL Espinosa de los Monteros, E Sosa, S Cheng, V Mendoza, ...
Hormone Research in Paediatrics 62 (6), 293-299, 2004
572004
GSPα mutations in Mexican patients with acromegaly: potential impact on long term prognosis
V Mendoza, E Sosa, AL Espinosa-de-Los-Monteros, M Salcedo, G Guinto, ...
Growth hormone & IGF research 15 (1), 28-32, 2005
442005
Efficacy and safety of radiotherapy in acromegaly
B González, G Vargas, AL Espinosa-de-los-Monteros, E Sosa, M Mercado
Archives of Medical Research 42 (1), 48-52, 2011
412011
Changing patterns of insulin-like growth factor—I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly
AL Espinosa-De-Los-Monteros, M Mercado, E Sosa, O Lizama, G Guinto, ...
Journal of neurosurgery 97 (2), 287-292, 2002
402002
Artículos de revisión. Diagnóstico y tratamiento actual de la hiperprolactinemia.
V Melgar, E Espinosa, E Sosa, MJ Rangel, D Cuenca, C Ramírez, ...
Revista Médica del Instituto Mexicano del Seguro Social, 2016
39*2016
Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors
K Taniguchi-Ponciano, S Andonegui-Elguera, E Peña-Martínez, ...
Scientific Reports 10 (1), 19373, 2020
382020
Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR
E Sosa-Eroza, E Espinosa, C Ramírez-Rentería, V Mendoza, R Arreola, ...
Endocrine 61, 343-348, 2018
372018
Octreotide LAR treatment of acromegaly in “real life”: long-term outcome at a tertiary care center
AL Espinosa-de-los-Monteros, B Gonzalez, G Vargas, E Sosa, M Mercado
Pituitary 18, 290-296, 2015
362015
Long-term outcome of the different treatment alternatives for recurrent and persistent cushing disease
AL Espinosa-de-Los-Monteros, E Sosa-Eroza, E Espinosa, V Mendoza, ...
Endocrine Practice 23 (7), 759-767, 2017
342017
AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience
C Ramírez-Rentería, LC Hernández-Ramírez, L Portocarrero-Ortiz, ...
Endocrine 53, 402-411, 2016
312016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20